Gregoire Le Gal

Gregoire Le Gal

MD, PhD

Senior Scientist, Inflammation and Chronic Disease

Ottawa Hospital Research Institute

Professor, Department of Medicine

University of Ottawa

Program Director, Inflammation and Chronic Disease

Ottawa Hospital Research Institute

Contact

613-737-8899, ext 73034

Bio

Dr. Grégoire Le Gal, M.D., Ph.D., is a Professor in the Division of Hematology of the Department of Medicine at the University of Ottawa, a physician in the Thrombosis Program, Division of Hematology at Ottawa Hospital, and a Senior Scientist in the Ottawa Hospital Research Institute, Clinical Epidemiology Program since July 2012. He was born and trained in France. 

His primary research interest is the diagnosis and management of venous thromboembolism (VTE), including the clinical diagnosis of VTE, and the derivation and validation of clinical decision rules for VTE. He has 233 peer-reviewed publications in general internal medicine and specialized journals and has had multiple international speaking invitations. He is a member of the international advisory board of the Journal of Thrombosis and Haemostasis, and a reviewer for main general internal medicine and thrombosis Journals. He has been the principal investigator of several multicenter multinational projects on the diagnosis and management of VTE. He is currently the Principal Investigator of four peer-reviewed clinical studies (Programme Hospitalier de Recherche Clinique, Ministry of Health, France). 
 

Research Goals and Interests

Dr. Le Gal's primary research interest is the diagnosis and management of venous thromboembolism (VTE), including the clinical diagnosis of VTE, and the derivation and validation of clinical decision rules for VTE.


News


Publications

COPD exacerbation purulence status and its association with pulmonary embolism: a systematic review with meta-analysis

2025-11-01 Go to publication

Sex-specific DNA methylation marks associated with sex-biased risk of recurrence in unprovoked venous thromboembolism

2025-01-01

Prediction of health-related quality-of-life results after lung stereotactic body radiotherapy using dose-volume parameters from functional mapping on Gallium-68 perfusion PET/CT

2025-01-01

Role of functional mapping on Gallium-68 perfusion positron emission tomography and computed tomographic imaging (PET/CT) to assess the risk of long-term radiation-induced lung toxicity after stereotactic body radiation therapy

2025-01-01

Residual pulmonary vascular obstruction computed with ventilation/perfusion single photon emission computed tomography/computed tomography to predict the risk of venous thromboembolism recurrence in patients with pulmonary embolism: protocol for a cohort

2025-01-01

Related Research at The Ottawa Hospital